Clinical trial
Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to…
NCT00562289 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00562289 |
|---|---|
| Title | Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence |
| Official title | Closure of Patent Foramen Ovale or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence |
| Acronym | CLOSE |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke, Patent Foramen Ovale, Atrial Septal Aneurysm, Migraine |
| Intervention type | Device, Drug |
| Interventions | aspirin, Antivitamins K or rivaroxaban or dabigatran or apixaban, Devices for PFO closure |
| Enrollment | 664 |
| Start date | Dec 1, 2007 |
| Primary completion | Dec 1, 2016 |
| Completion | Dec 1, 2016 |
| First posted | Nov 22, 2007 |
| Last update posted | Oct 19, 2017 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: